Nachrichten zur Novavax Inc. Aktie

Novavax, Inc. (NVAX) Jefferies London Healthcare Conference (Transcript)

…

Novavax Aktie: Reduzierte Umsatzprognose belastet - BofA bleibt neutral

Charlotte (www.aktiencheck.de) - Novavax-Aktienanalyse von BofA Securities: Aktuelle Bewertung BofA hat das Kursziel für Novavax Inc. (ISIN: US6700024010, WKN: A2PKMZ, Ticker-Symbol: NVV1,…

Novavax, Inc. (NVAX) Q3 2024 Earnings Call Transcript

…

Novavax shares tumble after clinical hold on flu combo vaccine

Novavax, Inc. (NASDAQ:NVAX) shares plummeted on Wednesday on news it faced a clinical hold on its CIC flu combination vaccine…

Novavax Aktie bricht ein - Grippe-Kombinationsimpfstoff scheitert vorerst an FDA

Kulmbach (www.aktiencheck.de) - Novavax-Aktienanalyse von "Der Aktionär": Michel Doepke vom Anlegermagazin "Der Aktionär" nimmt die Aktie von Novavax Inc. (ISIN: US6700024010,…

Novavax Plunges After FDA Hold on Flu, Covid Vaccine Work

Novavax Inc. shares fell as much as 24% after US regulators placed a hold on the company’s experimental influenza and…

Novavax Aktie: Starke Verkaufstrends und Partnerschaftspotenzial - Kaufempfehlung!

Arlington, VA (www.aktiencheck.de) - Novavax-Aktienanalyse von B. Riley Securities: Aktuelle Bewertung B. Riley-Analyst, Mayank Mamtani, hat das Kursziel für Novavax Inc. (ISIN:…

Novavax Aktie: Erfolgskurs! Umsatzprognose für 2024 bestätigt - Potenzial für langfristige Partnerschaften

New York (www.aktiencheck.de) - Novavax-Aktienanalyse von Jefferies & Co: Aktuelle Bewertung Jefferies sieht Novavax Inc. (ISIN: US6700024010, WKN: A2PKMZ, Ticker-Symbol: NVV1, NASDAQ-Symbol:…

Novavax, Inc. (NVAX) Baird 2024 Global Healthcare Conference (Transcript)

…

Novavax, Inc. (NVAX) H.C. Wainwright 26th Annual Global Investment Conference (Transcript)

…

Novavax: Kursziel gekappt

Arlington, VA (www.aktiencheck.de) - Rating-Update: Die Analysten von B. Riley Securities stufen die Aktie von Novavax Inc. (ISIN: US6700024010, WKN: A2PKMZ,…

Novavax: Kursziel reduziert

Arlington, VA (www.aktiencheck.de) - Rating-Update: Die Analysten von B. Riley Securities stufen die Aktie von Novavax Inc. (ISIN: US6700024010, WKN: A2PKMZ,…

Novavax: Die aktuellen Aktienkurse überbewerten die Einnahmen von Nuvaxovid erheblich - Downgrade - Aktienanalyse

New York (www.aktiencheck.de) - Novavax-Aktienanalyse von J.P. Morgan Securities: Die Analysten von J.P. Morgan Securities stufen die Aktie von Novavax Inc.…

Novavax: Kursziel gekürzt

New York (www.aktiencheck.de) - Rating-Update: Roger Song, Analyst von Jefferies & Co, senkt für die Aktie von Novavax Inc. (ISIN: US6700024010,…

Novavax Aktie: Mitarbeiterverkäufe und Zukunftsaussichten

Novavax Inc., ein Biotechnologieunternehmen mit dem Fokus auf die Entwicklung innovativer Impfstoffe, hat kürzlich Aktivitäten seiner Führungskräfte verzeichnet, die einen…

Novavax: Sanofi als idealer Partner für Nuvaxovid - Aktienanalyse

Charlotte (www.aktiencheck.de) - Novavax-Aktienanalyse von BofA Securities: Alec Stranahan, Analyst von BofA Securities, erhöht das Kursziel für die Aktie von Novavax…

Novavax, Inc. (NVAX) Jefferies 2024 Global Healthcare Conference (Transcript)

…

Novavax: Lang erwarteter Wendepunkt - Kursziel nahezu verdreifacht! Aktienanalyse

Arlington, VA (www.aktiencheck.de) - Novavax-Aktienanalyse von B. Riley Securities: Mayank Mamtani, Analyst von B. Riley Securities, stuft die Aktie von Novavax…

Biotech Stock Roundup: NVAX, FULC Up on Deals With SNY, Updates From MRNA, BMY

Novavax, Inc (NVAX) and Fulcrum Therapeutics, Inc (FULC) are in the spotlight following license agreements with pharma giant Sanofi.…

Novavax: Kursziel erhöht

New York (www.aktiencheck.de) - Rating-Update: Die Analysten von TD Cowen stufen die Aktie von Novavax Inc. (ISIN: US6700024010, WKN: A2PKMZ, Ticker-Symbol:…

Novavax: "buy"

New York (www.aktiencheck.de) - Rating-Update: Die Analysten von H.C. Wainwright & Co wiederholen das Rating "buy" und das Kursziel 19 USD…

Novavax: Bullishes Momentum - Aktienanalyse

Kulmbach (www.aktiencheck.de) - Novavax-Aktienanalyse von "Der Aktionär": Michael Diertl vom Anlegermagazin "Der Aktionär" nimmt in einer aktuellen Aktienanalyse die Aktie von…

Novavax: Hochstufung wegen Vertrags mit Sanofi - Kursziel verdreifacht! Aktienanalyse

Charlotte (www.aktiencheck.de) - Novavax-Aktienanalyse von BofA Securities: Die Analysten von BofA Securities stufen die Aktie von Novavax Inc. (ISIN: US6700024010, WKN:…

Novavax: Lizenzvereinbarung mit Sanofi - Upgrade! Aktienanalyse

New York (www.aktiencheck.de) - Novavax-Aktienanalyse von J.P. Morgan Securities: Eric Joseph, Analyst von J.P. Morgan Securities, stuft die Aktie von Novavax…

Novavax, Inc. (NVAX) Q1 2024 Earnings Call Transcript

…

Novavax shares skyrocket after billion-dollar licensing deal with Sanofi

Novavax, Inc. (NASDAQ:NVAX) shares surged Friday following the announcement of a significant licensing agreement with Sanofi SA (ADR) (NYSE:SNY), valued…

Novavax: Dreistelliges Kursplus! - Aktienanalyse

Kulmbach (www.aktiencheck.de) - Novavax-Aktienanalyse von "Der Aktionär": Michel Doepke vom Anlegermagazin "Der Aktionär" nimmt in einer aktuellen Aktienanalyse die Aktie von…

Sanofi Signs $1.2 Billion Vaccine Licensing Deal With Novavax

Sanofi and Novavax Inc. signed a licensing agreement that includes commercializing a combined Covid-19 and flu shot.…

Novavax Inc. stock outperforms competitors on strong trading day

Shares of Novavax Inc. rose 3.75% to $5.25 Wednesday, on what proved to be an all-around mixed trading session for…

Novavax, Inc. (NVAX) TD Cowens 44th Annual Health Care Conference - (Transcript)

…

Novavax, Inc. 2023 Q4 - Results - Earnings Call Presentation

…

Novavax sheds a quarter of its value as sales look to remain pressured

Novavax, Inc. (NASDAQ:NVAX) shares fell over 27% on Wednesday as the Covid-19 vaccine maker warned of slowing sales ahead after…

Novavax, Inc. (NVAX) Q4 2023 Earnings Call Transcript

…

Novavax: Kein Investment wert - Aktienanalyse

Kulmbach (www.aktiencheck.de) - Novavax-Aktienanalyse von "Der Aktionär": Thomas Bergmann vom Anlegermagazin "Der Aktionär" nimmt in einer aktuellen Aktienanalyse die Aktie von…

Novavax, Inc. (NVAX) CEO John Jacobs Presents at JPMorgan 42nd Annual Healthcare Conference Transcript

…

Novavax Inc. stock outperforms market on strong trading day

Shares of Novavax Inc. rallied 2.43% to $5.06 Friday, on what proved to be an all-around mixed trading session for…

: Novavax’s stock pops after WHO grants its COVID-19 vaccine emergency-use listing

Novavax Inc.’s stock NVAX soared 4.6% early Tuesday, after the company said its protein-based COVID-19 vaccine had been granted emergency-use…

Novavax, Inc. (NVAX) Presents at Jefferies London Healthcare Conference (Transcript)

…

Novavax, Inc. 2023 Q3 - Results - Earnings Call Presentation

…

Novavax, Inc. (NVAX) Q3 2023 Earnings Call Transcript

…

The Zacks Analyst Blog Highlights Regeneron Pharmaceuticals, Gilead Sciences, Novavax, Apellis Pharmaceuticals and Fulcrum Therapeutics

Regeneron Pharmaceuticals, Gilead Sciences, Novavax, Apellis Pharmaceuticals and Fulcrum Therapeutics are part of the Zacks top Analyst Blog....…

Are These 2 Companies Next for Short Squeezes?

Novavax and Seritage Growth Properties have unusually high short interest and potential short squeeze catalysts....…

CDC expects new Covid vaccines from Pfizer, Moderna and Novavax to be available in mid-September

The updated Covid vaccines from Pfizer, Moderna and Novavax still need green lights from the FDA and the CDC before…

Novavax (NVAX) Updated COVID Jab Effective Against Eris Variant

In studies on small animals and primates, Novavaxs (NVAX) updated monovalent COVID-19 vaccine generates a robust immune response against the…

Why Are Shares of Novavax Soaring Today?

The vaccine maker just gave investors some good news....…

Novavax Shares Jump 13% on Effectiveness of Covid-19 Vaccine Against Subvariants

Novavax Shares Jump 13% on Effectiveness of Covid-19 Vaccine Against Subvariants...…

Novavax says new Covid vaccine was effective against Eris variant in animal trials

Novavaxs vaccine and new shots from Pfizer and Moderna are expected to roll out in the U.S. within weeks, pending…

Novavax says updated COVID vaccine effective against Eris, other new variants

Novavax Inc. NVAX said Tuesday that its updated COVID-19 vaccine has shown promise against newer strains of the virus. In…

Novavax says updated COVID shot neutralized new Omicron strains

Um den gesamten Artikel unter seekingalpha.com zu lesen, klicken Sie bitte auf die Überschrift...…

Why Moderna, BioNTech SE, and Novavax Surged Today

The companies have developed vaccines for the current dominant strain of COVID, and the Biden administration is getting behind a…